Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Fortum Monovial 2g powder for solution for injection vials
0501021H0BBAHAC
|
Fortum | Ceftazidime pentahydrate | Infections | No data available |
|
Fortuna Fast stockinette 17.5cm
20090001180
|
Fortuna Fast stockinette 17.5cm | Stockinette | Dressings | No data available |
|
Fortuna Fast stockinette 3.5cm
20090001170
|
Fortuna Fast stockinette 3.5cm | Stockinette | Dressings | No data available |
|
Fortuna Fast stockinette 5cm
20090001171
|
Fortuna Fast stockinette 5cm | Stockinette | Dressings | No data available |
|
Fosachew 1500mg chewable tablets
1001050A0BUAAAC
|
Fosachew | Glucosamine hydrochloride (Rheumatic) | Musculoskeletal and Joint Diseases | No data available |
|
Fosachew 500mg/400mg chewable tablets
1001050A0BUABAD
|
Fosachew | Glucosamine hydrochloride (Rheumatic) | Musculoskeletal and Joint Diseases | No data available |
|
Fosamax 10mg tablets
0606020A0BBAAAA
|
Fosamax | Alendronic acid | Endocrine System | No data available |
|
Fosamax 5mg tablets
0606020A0BBABAB
|
Fosamax | Alendronic acid | Endocrine System | No data available |
|
Fosamprenavir 50mg/ml oral suspension
0503010M0AAABAB
|
Fosamprenavir calcium | Fosamprenavir calcium | Infections | No data available |
|
Fosamprenavir 700mg tablets
0503010M0AAAAAA
|
Fosamprenavir calcium | Fosamprenavir calcium | Infections | No data available |
|
Fosaprepitant 115mg powder for solution for infusion vials
0406000AEAAAAAA
|
Fosaprepitant | Fosaprepitant | Central Nervous System | No data available |
|
Fosaprepitant 150mg powder for solution for infusion vials
0406000AEAAABAB
|
Fosaprepitant | Fosaprepitant | Central Nervous System | No data available |
|
Fosaveg 750mg tablets
1001050A0BVAAAB
|
Fosaveg | Glucosamine hydrochloride (Rheumatic) | Musculoskeletal and Joint Diseases | No data available |
|
Foscan 1mg/1ml solution for injection vials
0801050AKBBABAB
|
Foscan | Temoporfin | Malignant Disease and Immunosuppression | No data available |
|
Foscan 20mg/5ml solution for injection vials
0801050AKBBAAAA
|
Foscan | Temoporfin | Malignant Disease and Immunosuppression | No data available |
|
Foscan 3mg/3ml solution for injection vials
0801050AKBBACAC
|
Foscan | Temoporfin | Malignant Disease and Immunosuppression | No data available |
|
Foscan 6mg/6ml solution for injection vials
0801050AKBBADAD
|
Foscan | Temoporfin | Malignant Disease and Immunosuppression | No data available |
|
Foscarnet sodium 6g/250ml solution for infusion bottles
0503022E0AAABAB
|
Foscarnet sodium | Foscarnet sodium | Infections | No data available |
|
Foscavir 6g/250ml solution for infusion bottles
0503022E0BBABAB
|
Foscavir | Foscarnet sodium | Infections | No data available |
|
Fosfestrol 120mg tablets
0803010D0AAADAD
|
Fosfestrol Tetraso | Fosfestrol tetrasodium | Malignant Disease and Immunosuppression | No data available |
|
Fosfestrol 300mg/5ml solution for injection ampoules
0803010D0AAACAC
|
Fosfestrol Tetraso | Fosfestrol tetrasodium | Malignant Disease and Immunosuppression | No data available |
|
Fosfocina 500mg capsules
0501130S0BBAAAA
|
Fosfocina | Fosfomycin calcium | Infections | No data available |
|
Fosinopril 20mg/5ml oral liquid
0205051J0AAACAC
|
Fosinopril sodium | Fosinopril sodium | Cardiovascular System | No data available |
|
Fosphenytoin 750mg/10ml solution for injection vials
0408020U0AAAAAA
|
Fosphenytoin sodium | Fosphenytoin sodium | Central Nervous System | No data available |
|
Fostemsavir 600mg modified-release tablets
0503010AXAAAAAA
|
Fostemsavir | Fostemsavir | Infections | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.